收费全文 | 13208篇 |
免费 | 763篇 |
国内免费 | 454篇 |
耳鼻咽喉 | 26篇 |
儿科学 | 278篇 |
妇产科学 | 99篇 |
基础医学 | 1848篇 |
口腔科学 | 135篇 |
临床医学 | 1528篇 |
内科学 | 2457篇 |
皮肤病学 | 147篇 |
神经病学 | 592篇 |
特种医学 | 213篇 |
外科学 | 626篇 |
综合类 | 2048篇 |
预防医学 | 732篇 |
眼科学 | 74篇 |
药学 | 2708篇 |
9篇 | |
中国医学 | 603篇 |
肿瘤学 | 302篇 |
2023年 | 81篇 |
2022年 | 183篇 |
2021年 | 362篇 |
2020年 | 355篇 |
2019年 | 253篇 |
2018年 | 319篇 |
2017年 | 315篇 |
2016年 | 385篇 |
2015年 | 323篇 |
2014年 | 664篇 |
2013年 | 959篇 |
2012年 | 662篇 |
2011年 | 752篇 |
2010年 | 587篇 |
2009年 | 527篇 |
2008年 | 579篇 |
2007年 | 611篇 |
2006年 | 575篇 |
2005年 | 545篇 |
2004年 | 510篇 |
2003年 | 466篇 |
2002年 | 409篇 |
2001年 | 343篇 |
2000年 | 340篇 |
1999年 | 308篇 |
1998年 | 263篇 |
1997年 | 269篇 |
1996年 | 229篇 |
1995年 | 227篇 |
1994年 | 201篇 |
1993年 | 185篇 |
1992年 | 181篇 |
1991年 | 152篇 |
1990年 | 149篇 |
1989年 | 130篇 |
1988年 | 128篇 |
1987年 | 104篇 |
1986年 | 89篇 |
1985年 | 127篇 |
1984年 | 144篇 |
1983年 | 80篇 |
1982年 | 80篇 |
1981年 | 58篇 |
1980年 | 54篇 |
1979年 | 27篇 |
1978年 | 32篇 |
1977年 | 27篇 |
1976年 | 19篇 |
1975年 | 12篇 |
1974年 | 16篇 |
Introduction
Type 1 diabetes mellitus (T1DM) is a chronic, autoimmune disease that is characterized by total absence of insulin production. Hypertension is a common comorbidity in T1DM with complex pathophysiology, while it is also a well-recognized risk factor for the development of cardiovascular disease (CVD), as well as other microvascular diabetic complications. 相似文献Objective
To assay peripheral inter-ictal cytokine serum levels and possible relations with non-invasive vagus nerve stimulation (nVNS) responsiveness in migraineurs.Methods
This double-blinded, sham-controlled study enrolled 48 subjects and measured headache severity, frequency [headache days/month, number of total and mild/moderate/severe classified attacks/month], functional state [sleep, mood, body weight, migraine-associated disability] and serum levels of inflammatory markers [inter-ictal] using enzyme-linked immunoassays at baseline and after 2 months of adjunctive nVNS compared to sham stimulation and suitably matched controls.Results
No significant differences were observed at baseline and after 2 months for headache severity, total attacks/month, headache days/month and functional outcome [sleep, mood, disability] between verum and sham nVNS. However, the number of severe attacks/month significantly decreased in the verum nVNS group and circulating pro-inflammatory IL-1β was elevated significantly in the sham group compared to nVNS. Levels of anti-inflammatory IL-10 were significantly higher at baseline in both groups compared to healthy controls, but not at 2 months follow-up [p?<?0.05]. Concentrations of high-mobility group box-1 (HMGB-1), IL-6, tumor-necrosis factor-α (TNF-α), leptin, adiponectin, ghrelin remained unchanged [p?>?0.05]. No severe device-/stimulation-related adverse events occurred.Conclusion
2 months of adjunctive cervical nVNS significantly declined the number of severe attacks/month. Pro-inflammatory IL-1β plasma levels [inter-ictal] were higher in sham-treated migraine patients compared to verum nVNS. However, pro- [IL-6, HMGB-1, TNF-α, leptin] and anti-inflammatory [IL-10, adiponectin, ghrelin] mediators did not differ statistically. Profiling of neuroinflammatory circuits in migraine to predict nVNS responsiveness remains an experimental approach, which may be biased by pre-analytic variables warranting large-scale biobank-based systematic investigations [omics]. 相似文献Butyrylcholinesterase (BChE) is a serine esterase that plays a role in the detoxification of natural as well as synthetic ester-bond-containing compounds. Alterations in BChE activity are associated with a number of diseases. Cholinergic system abnormalities in particular are correlated with the formation of senile plaques in Alzheimer’s disease (AD), and administration of cholinesterase inhibitors is a common therapeutic approach used to treat AD.
Here, our aim was to study the interaction between BChE and fluoxetine.
Molecular docking simulations revealed that fluoxetine penetrated deep into the active-site gorge of BChE and that it was engaged in stabilizing noncovalent interactions with multiple subsites. In substrate kinetic studies, the Vm, Km, kcat and kcat/Km values were found to be 20.59?±?0.36?U mg?1 protein, 194?±?14?µM, 1.3?×?108?s?1 and 6.7?×?105?µM?1s?1, respectively. Based on inhibitory studies, fluoxetine appeared to inhibit BChE competitively, with an IC50 value of 104?µM and a Ki value of 36.3?±?4.7?µM.
Overall, both the low Ki value and the high number of BChE–fluoxetine interactions suggest that fluoxetine is a potent inhibitor of BChE, although in vivo mechanisms for the direct effects of BChE inhibition on various pathologies remain to be further investigated.